Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial Prof Paul Little, FRCGP, Beth Stuart, PhD, Michael Moore, FRCGP, Prof Samuel Coenen, DMSc, Prof Christopher C Butler, FRCGP, Prof Maciek Godycki-Cwirko, PhD, Prof Artur Mierzecki, PhD, Slawomir Chlabicz, PhD, Prof Antoni Torres, PhD, Jordi Almirall, MD, Mel Davies, MSc, Tom Schaberg, PhD, Prof Sigvard Mölstad, PhD, Prof Francesco Blasi, MD, An De Sutter, PhD, Prof Janko Kersnik, PhD, Helena Hupkova, PhD, Pia Touboul, MD, Prof Kerenza Hood, PhD, Mark Mullee, MSc, Gilly O'Reilly, PhD, Curt Brugman, MSc, Prof Herman Goossens, PhD, Prof Theo Verheij, PhD The Lancet Infectious Diseases Volume 13, Issue 2, Pages 123-129 (February 2013) DOI: 10.1016/S1473-3099(12)70300-6 Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 1 Trial profile The Lancet Infectious Diseases 2013 13, 123-129DOI: (10.1016/S1473-3099(12)70300-6) Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 2 Kaplan-Meier estimates for duration of symptoms rated “moderately bad” or worse The Lancet Infectious Diseases 2013 13, 123-129DOI: (10.1016/S1473-3099(12)70300-6) Copyright © 2013 Elsevier Ltd Terms and Conditions